MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hrthm.2022.04.008

Медицинская библиотека · Heart rhythm · 2022

Early trends in leadless pacemaker implantation: Evaluating nationwide in-hospital outcomes.

Vincent Louis, Grant Jelani, Peñalver Jorge, Ebner Bertrand, Maning Jennifer, Olorunfemi Odunayo, Goldberger Jeffrey J, Mitrani Raul D

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Single-chamber leadless intracardiac pacemaker (LICP) implantation was approved in 2016 in the United States. However, little is known regarding trends in real-world utilization and complication rates.

OBJECTIVE

The purpose of this study was to assess nationwide demographics, trends, and outcomes among hospitalizations with LICP implantation in the United States.

METHODS

Using the National Inpatient Sample, we identified all hospitalizations with LICP or transvenous pacemaker implantation as a comparator between 2017 and 2019. We evaluated baseline patient characteristics, admitting diagnoses, procedural complications, lengths of stay, discharge dispositions, and all-cause mortality.

RESULTS

The majority of LICP recipients were elderly (75.4 ± 12.8 years), male (55.2%), and White (76.8%) compared to Black (9.8%), or Hispanic (7.3%). Between 2017 and 2019, the average age increased along with the prevalence of heart failure, atrial fibrillation, and malignancy among recipients. Most hospitalizations were emergent (84.5%). Between 2017 and 2019, pooled procedural complications decreased significantly (10.8% vs 7.9%; P <.001), primarily due to declining infection and device retrieval rates. In-hospital mortality also decreased significantly (8.2% vs 4.2%; P <.001). History of cardiogenic shock or cardiac device infection was associated with the greatest mortality or complication risk. Compared to transvenous pacemaker, LICP implantation was associated with lower complication rates (8.6% vs 11.2%) but greater mortality (5.2% vs 1.3%; P <.001).

CONCLUSION

Nationwide LICP implantations were performed in patients of increasing age, comorbidities, and acuity of illness. In-hospital mortality and procedure-related complications declined in the first 3 years after approval of LICP implantation and may reflect improving operator experience. Increased mortality compared with transvenous pacemaker implant remains a concern.

Для цитирования: Vincent Louis, Grant Jelani, Peñalver Jorge, Ebner Bertrand, Maning Jennifer, Olorunfemi Odunayo, Goldberger Jeffrey J, Mitrani Raul D. Early trends in leadless pacemaker implantation: Evaluating nationwide in-hospital outcomes.. Heart rhythm. 2022. DOI: 10.1016/j.hrthm.2022.04.008.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.